EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Randomised Double-Blind Trial of Combination Antibiotic Therapy in Rheumatoid Arthritis

Angela Smith, Caroline Doré, Peter Charles, Alena Vallance, Tara Potier, Charles Mackworth-Young

International Journal of Rheumatology · 2011 · 2011 · 1-6

DOI: 10.1155/2011/585497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatology, 2011. Verfasst von Angela Smith und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kennedy Institute of Rheumatology, 1 Aspenlea Road, London W6 8LH, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Medical Research Council, Peacock Trust.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A combination of intravenous clindamycin and oral tetracycline has been used for many years as a treatment for active rheumatoid arthritis (RA), despite the absence of good evidence for its efficacy. A single-blind pilot study of this therapy suggested that a double-blind placebo-controlled trial was warranted.

Methods

Patients with active RA were randomised in a 2 : 1 ratio to receive active treatment or placebo for 25 weeks. The active treatment consisted of intravenous clindamycin in a reducing regime, and oral tetracycline twice daily three times a week. 50 patients were to be recruited. The primary outcome measure was the proportion of patients achieving an ACR20 response.

Results

An interim statistical analysis was performed after 20 patients had completed the study. Two patients in the active group achieved an ACR20 response, with none in the placebo group (NS). There was a better ESR20 response in the placebo group ( P = . 02 ). There were no other significant differences between the groups. The results indicated that it was unlikely that a significant difference in ACR20 response would emerge if the remaining 30 patients were recruited. The trial was therefore halted.

Conclusion

This antibiotic regime is unlikely to be a valuable therapy for active rheumatoid arthritis.

Autor:innen und Institutionen

  • Kennedy Institute of Rheumatology, 1 Aspenlea Road, London W6 8LH, UK.

Förderung

  • Medical Research Council
  • Peacock Trust

Zitieren

APA

Smith, A., Doré, C., Charles, P., Vallance, A., Potier, T., & Mackworth-Young, C. (2011). Randomised Double-Blind Trial of Combination Antibiotic Therapy in Rheumatoid Arthritis. International Journal of Rheumatology, 2011, 1-6. https://doi.org/10.1155/2011/585497

Vancouver

Smith A, Doré C, Charles P, Vallance A, Potier T, Mackworth-Young C. Randomised Double-Blind Trial of Combination Antibiotic Therapy in Rheumatoid Arthritis. International Journal of Rheumatology. 2011;2011:1-6. doi:10.1155/2011/585497

BibTeX
@article{Smith2011,
  author = {Smith, Angela and Doré, Caroline and Charles, Peter and Vallance, Alena and Potier, Tara and Mackworth-Young, Charles},
  title = {Randomised Double-Blind Trial of Combination Antibiotic Therapy in Rheumatoid Arthritis},
  journal = {International Journal of Rheumatology},
  year = {2011},
  volume = {2011},
  pages = {1--6},
  doi = {10.1155/2011/585497}
}
Kostenlos starten →